Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin for Premature Ovarian Failure
ChiCTR2100045312Phase 4Recruiting
- Sponsor
- Shanghai First Maternal and Infant Health Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of niacin in ovarian hypofunction (POI) (2 arms), sponsored by Shanghai First Maternal and Infant Health Hospital. Primary endpoint: Follicle-stimulating hormone. Started Apr 2021; status: recruiting.
02
Drugs
niacin
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on ChiCTR2100045312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045312.